Aspire Private Capital’s Neos Therapeutics, Inc NEOS Stock Holding History

Aspire Private Capital’s Portfolio NEOS Stock Details NEOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-50	Closed	–	–	628
2020 Q4	$0	Buy	+50	New	+$31	﹤0.01%	560
2020 Q1	–	Sell	-50	Closed	–	–	528
2019 Q4	$0	Buy	+50	New	+$75	﹤0.01%	554

Aspire Private Capital's NEOS Position: Q1 2021 in Review

Aspire Private Capital sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 50 shares.

Aspire Private Capital first reported a position in NEOS in Q4 2019 and held it in 2 quarters. The position peaked at $0 in Q4 2020. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.

Aspire Private Capital reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
Aspire Private Capital sold 50 Neos Therapeutics, Inc shares in Q1 2021.
Aspire Private Capital first reported a position in Neos Therapeutics, Inc in Q4 2019 and held it in 2 quarters.
Aspire Private Capital's Neos Therapeutics, Inc position peaked at $0 in Q4 2020.
0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.

Based on Aspire Private Capital's 13F filing for Q1 2021, filed 26 May 2021.